ClinicalTrials.Veeva

Menu

Probiotics and Intestinal Microbiome in Preterm Infants

B

Belal Alshaikh

Status and phase

Completed
Phase 3

Conditions

Microbial Colonization

Treatments

Dietary Supplement: Florababy

Study type

Interventional

Funder types

Other

Identifiers

NCT03422562
REB16-0542

Details and patient eligibility

About

The gut microbiome plays a significant role in balancing the inflammatory system in the immature gut. A breakdown in this balance with altered colonization of the microbiota in very low birth weight (VLBW) preterm infants is associated with increased feeding intolerance, necrotizing enterocolitis (NEC) and sepsis. Probiotics are proposed to normalize microbial populations and decrease intestinal disease in preterm infants. There is limited data linking clinical outcomes with the biology of probiotics. We aim to study the colonization of the GI tract with probiotic species contained in a specific probiotic blend - Florababy - in VLBW preterm infants.

Stool microbiome will be analyzed at 4 time points in 2 groups (one given Florababy and the other no) of infants less than 1000 grams birth weight and < 29 weeks gestation. A comparison of stool microbiome analysis and the incidence of feeding intolerance and time to reach full feeds in the two groups will be made.

Enrollment

62 patients

Sex

All

Ages

23 to 29 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infants born less than 29 weeks gestation and <1000 g birth weight admitted to the Neonatal Intensive Care Unit (NICU) at Foothills Medical Centre in Calgary.

Exclusion criteria

  • Infants with major congenital anomalies, hypoxic-ischemic injury, NEC or bowel perforation before 72 hours of life.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

62 participants in 2 patient groups

Probiotic
Active Comparator group
Description:
Florababy probiotic (0.5g per day) will be started at or after 72 hours of life and will be administered in 1ml sterile water prior to feed.
Treatment:
Dietary Supplement: Florababy
Control
No Intervention group
Description:
Standard of care arm

Trial documents
3

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems